Stay updated with breaking news from Therapy System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts predict that BioCardia, Inc. (NASDAQ:BCDA – Get Rating) will report earnings of ($0.22) per share for the current fiscal quarter, Zacks reports. Two analysts have made estimates for BioCardia’s earnings, with estimates ranging from ($0.33) to ($0.16). BioCardia posted earnings per share of ($0.18) during the same quarter last year, which indicates a negative […]
BioCardia (NASDAQ:BCDA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. According to Zacks, “BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company’s product candidate consists of CardiAMP(TM), […]
BioCardia (NASDAQ:BCDA – Get Rating) announced its quarterly earnings results on Tuesday. The company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.01, Fidelity Earnings reports. BioCardia had a negative return on equity of 72.74% and a negative net margin of 1,237.37%. During the same period in the […]
BioCardia (NASDAQ:BCDA – Get Rating) and Ablynx (OTCMKTS:ABLYF – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings. Analyst Ratings This is a summary of recent ratings and price targets […]
David Einhorn stocks did better than the S&P 500 in Q4 2021, gaining 18.6%, 760 basis points higher. Buy these seven holdings.